A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
Clinical trial NCT03573622 · COMPLETED
Trial details
- NCT number
- NCT03573622
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2018-08-21
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.